Procontractile G protein-mediated signaling pathways antagonistically regulate smooth muscle differentiation in vascular remodeling

Journal of Experimental Medicine

Volumn 209, Issue 12, 2012, Pages 2277-2290

  Althoff, Till F ^a   Juárez, Julián Albarrán ^a   Troidl, Kerstin ^a,b   Tang, Cong ^a   Wang, Shengpeng ^a   Wirth, Angela ^a,c   Takefuji, Mikito ^a   Wettschureck, Nina ^a,b   Offermanns, Stefan ^a,b  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN G ALPHA 11; G PROTEIN G ALPHA 12; G PROTEIN G ALPHA 13; G PROTEIN G ALPHA 9; G PROTEIN G11; G PROTEIN G12; G PROTEIN G13; G PROTEIN G9; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOTIDE BINDING PROTEIN; PROTEIN SM; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL INJURY; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE EXACERBATION; GENE EXPRESSION; MALE; MARKER GENE; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; APOLIPOPROTEINS E; BLOOD PRESSURE; BLOTTING, WESTERN; CELL DIFFERENTIATION; DNA PRIMERS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; REAL-TIME POLYMERASE CHAIN REACTION; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TELEMETRY;

EID: 84871872872     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20120350     Document Type: Article

References (58)

1. Andrawis, N.S., E. Wang, and D.R. Abernethy. 1996. Endothelin-1 induces an increase in total protein synthesis and expression of the smooth muscle alpha-actin gene in vascular smooth muscle cells. Life Sci. 59:523-528. http://dx.doi.org/10.1016/0024-3205(96)00332-3
2. Cho, H., C. Park, I.Y. Hwang, S.B. Han, D. Schimel, D. Despres, and J.H. Kehrl. 2008. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol. Cell. Biol. 28:2590-2597. http://dx.doi.org/10.1128/MCB.01889-07
3. Chun, J., T. Hla, K.R. Lynch, S. Spiegel, and W.H. Moolenaar. 2010.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 62:579-587. http://dx.doi.org/10.1124/pr.110.003111
4. Copeland, J.W., and R. Treisman. 2002. The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polym-erization. Mol. Biol. Cell. 13:4088-4099. http://dx.doi.org/10.1091/ mbc.02-06-0092
5. Dzau, V.J., R.C. Braun-Dullaeus, and D.G. Sedding. 2002. Vascular prolif-eration and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8:1249-1256. http://dx.doi.org/10.1038/nm1102-1249
6. Ferns, G.A., E.W. Raines, K.H. Sprugel, A.S. Motani, M.A. Reidy, and R. Ross. 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1129-1132. http://dx.doi.org/10.1126/science.1653454
7. Gohla, A., G. Schultz, and S. Offermanns. 2000. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ. Res. 87:221-227. http://dx.doi.org/10.1161/01.RES.87.3.221
8. Gorenne, I., L. Jin, T. Yoshida, J.M. Sanders, I.J. Sarembock, G.K. Owens, A.P. Somlyo, and A.V. Somlyo. 2006. LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury. Circ. Res. 98:378-385. http://dx.doi.org/10.1161/01.RES.0000202802.34727.fd
9. Guilluy, C., J. Brégeon, G. Toumaniantz, M. Rolli-Derkinderen, K. Retailleau, L. Loufrani, D. Henrion, E. Scalbert, A. Bril, R.M. Torres, et al. 2010. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat. Med. 16:183-190. http://dx.doi .org/10.1038/nm.2079
10. Gunaje, J.J., A.J. Bahrami, S.M. Schwartz, G. Daum, and W.M. Mahoney Jr. 2011. PDGF-dependent regulation of regulator of G protein signal-ing-5 expression and vascular smooth muscle cell functionality. Am. J. Physiol. Cell Physiol. 301:C478-C489. http://dx.doi.org/10.1152/ ajpcell.00348.2010
11. Herroeder, S., P. Reichardt, A. Sassmann, B. Zimmermann, D. Jaeneke, J. Hoeckner, M.W. Hollmann, K.D. Fischer, S. Vogt, R. Grosse, et al. 2009. Guanine nucleotide-binding proteins of the G12 family shape immune functions by controlling CD4+T cell adhesiveness and motility. Immunity. 30:708-720. http://dx.doi.org/10.1016/j.immuni.2009.02.010
12. Heximer, S.P., R.H. Knutsen, X. Sun, K.M. Kaltenbronn, M.H. Rhee, N. Peng, A. Oliveira-dos-Santos, J.M. Penninger, A.J. Muslin, T.H. Steinberg, et al. 2003. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111:1259.
13. Hsieh, H.L., W.H. Tung, C.Y. Wu, H.H. Wang, C.C. Lin, T.S. Wang, and C.M. Yang. 2009. Thrombin induces EGF receptor expression and cell proliferation via a PKC(delta)/c-Src-dependent pathway in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 29:1594-1601. http://dx.doi.org/10.1161/ATVBAHA.109.185801
14. Jeon, E.S., W.S. Park, M.J. Lee, Y.M. Kim, J. Han, and J.H. Kim. 2008. A Rho kinase/myocardin-related transcription factor-A-dependent mechanism underlies the sphingosylphosphorylcholine-induced differentiation of mesenchymal stem cells into contractile smooth muscle cells. Circ. Res. 103:635-642. http://dx.doi.org/10.1161/CIRCRESAHA.108.180885
15. Kim, M.R., E.S. Jeon, Y.M. Kim, J.S. Lee, and J.H. Kim. 2009. Thromboxane a(2) induces differentiation of human mesenchymal stem cells to smooth muscle-like cells. Stem Cells. 27:191-199. http://dx.doi.org/10.1634/stemcells.2008-0363.
16. Li, J., X. Zhu, M. Chen, L. Cheng, D. Zhou, M.M. Lu, K. Du, J.A. Epstein, and M.S. Parmacek. 2005. Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc. Natl. Acad. Sci. USA. 102:8916-8921. http://dx.doi.org/10.1073/pnas.0503741102.
17. Li, S., S. Chang, X. Qi, J.A. Richardson, and E.N. Olson. 2006. Requirement of a myocardin-related transcription factor for development of mammary myoepithelial cells. Mol. Cell. Biol. 26:5797-5808. http://dx.doi.org/ 10.1128/MCB.00211-06
18. Lockman, K., J.S. Hinson, M.D. Medlin, D. Morris, J.M. Taylor, and C.P. Mack. 2004. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J. Biol. Chem. 279:42422-42430. http://dx.doi.org/10.1074/ jbc.M405432200
19. Lorenz, K., J.P. Schmitt, E.M. Schmitteckert, and M.J. Lohse. 2009. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 15:75-83. http://dx.doi.org/10.1038/nm.1893.
20. Lu, J., T.E. Landerholm, J.S. Wei, X.R. Dong, S.P. Wu, X. Liu, K. Nagata, M. Inagaki, and M.W. Majesky. 2001. Coronary smooth muscle dif-ferentiation from proepicardial cells requires rhoA-mediated actin re-organization and p160 rho-kinase activity. Dev. Biol. 240:. http://dx.doi.org/10.1006/dbio.2001.0403
21. 2011. Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. 31:1495-1505. http:// dx.doi.org/10.1161/ATVBAHA.110.221135.
22. Mack, C.P., A.V. Somlyo, M. Hautmann, A.P. Somlyo, and G.K. Owens. 2001. Smooth muscle differentiation marker gene expression is regu-lated by RhoA-mediated actin polymerization. J. Biol. Chem. 276:341- 347. http://dx.doi.org/10.1074/jbc.M005505200.
23. Maguire, J.J., and A.P. Davenport. 2005. Regulation of vascular reactivity by established and emerging GPCRs. Trends Pharmacol. Sci. 26:448-454.
24. Martin, K., S. Weiss, P. Metharom, J. Schmeckpeper, B. Hynes, J. O'Sullivan, and N. Caplice. 2009. Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin. Circ. Res. 105:214-218. http://dx.doi.org/10.1161/CIRCRESAHA.109.199984
25. Medlin, M.D., D.P. Staus, A.D. Dubash, J.M. Taylor, and C.P. Mack. 2010. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. 30:1779-1786. http://dx.doi.org/10.1161/ ATVBAHA.110.209395.
26. Miano, J.M., X. Long, and K. Fujiwara. 2007. Serum response factor: mas-ter regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 292:C70-C81. http://dx.doi.org/10.1152/ ajpcell.00386.2006
27. Miralles, F., G. Posern, A.I. Zaromytidou, and R. Treisman. 2003. Actin dy-namics control SRF activity by regulation of its coactivator MAL. Cell. 113:329-342. http://dx.doi.org/10.1016/S0092-8674(03)00278-2
28. Moers, A., B. Nieswandt, S. Massberg, N. Wettschureck, S. Grüner, I. Konrad, V. Schulte, B. Aktas, M.P. Gratacap, M.I. Simon, et al. 2003. G13 is an essential mediator of platelet activation in hemostasis and throm-bosis. Nat. Med. 9:1418-1422. http://dx.doi.org/10.1038/nm943
29. Momotani, K., M.V. Artamonov, D. Utepbergenov, U. Derewenda, Z.S. Derewenda, and A.V. Somlyo. 2011. p63RhoGEF couples Gα(q/11)- mediated signaling to Ca2+ sensitization of vascular smooth muscle contractility. Circ. Res. 109:993-1002. http://dx.doi.org/10.1161/CIRCRESAHA .111.248898
30. Noma, K., Y. Rikitake, N. Oyama, G. Yan, P. Alcaide, P.Y. Liu, H. Wang, D. Ahl, N. Sawada, R. Okamoto, et al. 2008. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J. Clin. Invest. 118:1632-1644. http://dx.doi.org/10.1172/JCI29226
31. Oh, J., J.A. Richardson, and E.N. Olson. 2005. Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc. Natl. Acad. Sci. USA. 102:15122-15127. http://dx.doi.org/10.1073/pnas.0507346102.
32. Olson, E.N., and A. Nordheim. 2010. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat. Rev. Mol. Cell Biol. 11:353-365. http://dx.doi.org/10.1038/nrm2890
33. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
34. Owens, G.K. 2007. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found. Symp. 283:174-191, discussion :191-193: 238-241. http://dx.doi.org/10.1002/9780470319413.ch14.
35. Owens, G.K., M.S. Kumar, and B.R. Wamhoff. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:767-801. http://dx.doi.org/10.1152/physrev.00041.2003.
36. Parmacek, M.S. 2007. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ. Res. 100:633-644. http://dx.doi.org/10.1161/01.RES.0000259563.61091.e8
37. Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45.
38. Pipes, G.C., S. Sinha, X. Qi, C.H. Zhu, T.D. Gallardo, J. Shelton, E.E. Creemers, L. Sutherland, J.A. Richardson, D.J. Garry, et al. 2005. Stem cells and their derivatives can bypass the requirement of myocardin for smooth muscle gene expression. Dev. Biol. 288:502-513. http://dx.doi.org/10.1016/j.ydbio.2005.10.014.
39. Pipes, G.C., E.E. Creemers, and E.N. Olson. 2006. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, mi-gration, and myogenesis. Genes Dev. 20:1545-1556. http://dx.doi.org/10.1101/gad.1428006
40. Posern, G., and R. Treisman. 2006. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16:588-596. http://dx.doi.org/10.1016/j.tcb.2006.09.008
41. Raines, E.W. 2000. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int. J. Exp. Pathol. 81:173-182. http://dx.doi.org/10.1046/j.1365- 2613.2000.00155.x
42. Ray, J.L., R. Leach, J.M. Herbert, and M. Benson. 2001. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23:185-188. http://dx.doi.org/10.1023/A:1016357510143.
43. Reiter, E., S. Ahn, A.K. Shukla, and R.J. Lefkowitz. 2012. Molecular mechanism of Β-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52:179-197. http://dx.doi.org/10.1146/ annurev.pharmtox.010909.105800
44. Shimizu, T., T. Nakazawa, A. Cho, F. Dastvan, D. Shilling, G. Daum, and M.A. Reidy. 2007. Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries. Circ. Res. 101:995-1000. http://dx.doi.org/10.1161/CIRCRESAHA.107.159228
45. Somlyo, A.P., and A.V. Somlyo. 2003. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83:1325-1358.
46. Staus, D.P., A.L. Blaker, J.M. Taylor, and C.P. Mack. 2007. Diaphanous 1 and 2 regulate smooth muscle cell differentiation by activating the myocardinrelated transcription factors. Arterioscler. Thromb. Vasc. Biol. 27:478-486. http://dx.doi.org/10.1161/01.ATV.0000255559.77687.c1
47. Sun, Y., K. Boyd, W. Xu, J. Ma, C.W. Jackson, A. Fu, J.M. Shillingford, G.W. Robinson, L. Hennighausen, J.K. Hitzler, et al. 2006. Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function. Mol. Cell. Biol. 26:5809-5826. http://dx.doi.org/ 10.1128/MCB.00024-06
48. Tang, K.M., G.R. Wang, P. Lu, R.H. Karas, M. Aronovitz, S.P. Heximer, K.M. Kaltenbronn, K.J. Blumer, D.P. Siderovski, Y. Zhu, and M.E. Mendelsohn. 2003. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9:1506-1512. (published erratum appears in Nat. Med. 2004. 10:105) http://dx.doi.org/10.1038/nm958
49. Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:96-101. http://dx.doi.org/10.1016/0959-437X(94)90097-3
50. Valant, C., J. Robert Lane, P.M. Sexton, and A. Christopoulos. 2012. The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 52:153-178. http:// dx.doi.org/10.1146/annurev-pharmtox-010611-134514
51. Wamhoff, B.R., D.K. Bowles, O.G. McDonald, S. Sinha, A.P. Somlyo, A.V. Somlyo, and G.K. Owens. 2004. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ. Res. 95:406-414. http://dx.doi.org/10.1161/01.RES.0000138582.36921.9e
52. Wamhoff, B.R., K.R. Lynch, T.L. Macdonald, and G.K. Owens. 2008. Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler. Thromb. Vasc. Biol. 28:1454-1461. http://dx.doi.org/10.1161/ATVBAHA.107.159392
53. Wang, Z., D.Z. Wang, D. Hockemeyer, J. McAnally, A. Nordheim, and E.N. Olson. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature. 428:185-189. http:// dx.doi.org/10.1038/nature02382
54. Wettschureck, N., H. Rütten, A. Zywietz, D. Gehring, T.M. Wilkie, J. Chen, K.R. Chien, and S. Offermanns. 2001. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/ Galpha11 in cardiomyocytes. Nat. Med. 7:1236-1240. http://dx.doi .org/10.1038/nm1101-1236
55. Wirth, A., Z. Benyó, M. Lukasova, B. Leutgeb, N. Wettschureck, S. Gorbey, P. Orsy, B. Horváth, C. Maser-Gluth, E. Greiner, et al. 2008. G12-G13- LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 14:64-68. http://dx.doi.org/ 10.1038/nm1666
56. Wuertz, C.M., A. Lorincz, C. Vettel, M.A. Thomas, T. Wieland, and S. Lutz. 2010. p63RhoGEF-a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells. FASEB J. 24:4865- 4876.PubMed http://dx.doi.org/10.1096/fj.10-155499.
57. Xi, X.P., K. Graf, S. Goetze, W.A. Hsueh, and R.E. Law. 1997. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett. 417:283-286. http://dx.doi.org/10.1016/S0014-5793(97)01303-3.
58. Yoshida, T., M.H. Hoofnagle, and G.K. Owens. 2004. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin. Circ. Res. 94:1075-1082. http://dx.doi.org/10.1161/01 .RES.0000125622.46280.95